K

Novel Microdevices logo

Novel Microdevices

Healthcare & Life Sciences

Recent Finacing

Seed

Recent Raise

$8M


Novel Microdevices, Inc. develops a high-performance, point-of-care RT-PCR platform for rapid detection of respiratory viruses, including RSV, Influenza A, Influenza B, and COVID-19.

Total Funding

$11.5M

Headquarters

New York, USA

Founded

2020

Focus Areas

Clinical diagnostics
point-of-care
RT-PCR platform
rapid testing
respiratory viruses
laboratory-quality testing

Investors

Village Global logo
Nazca logo
Foundamental logo
Autotech Ventures logo
Nido Ventures logo
Bridge Latam logo